WTA
SYNH

Washington Trust Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Washington Trust Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-110
Closed -$3.92K – 785
2023
Q1 		$3.92K Hold
110
– – ﹤0.01% 648
2022
Q4 		$4.04K Buy
110
+2
+2% +$79 ﹤0.01% 638
2022
Q3 		$5K Hold
108
– – ﹤0.01% 733
2022
Q2 		$8K Buy
108
+9
+9% +$658 ﹤0.01% 677
2022
Q1 		$8K Buy
99
+11
+13% +$931 ﹤0.01% 751
2021
Q4 		$9K Buy
+88
New +$8.45K ﹤0.01% 756

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Washington Trust Advisors's SYNH Position: Q2 2023 in Review

Washington Trust Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 110 shares — an estimated $3.92K sold.

Washington Trust Advisors first reported a position in SYNH in Q4 2021 and held it in 6 quarters. The position peaked at $9K in Q4 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Washington Trust Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Washington Trust Advisors sold 110 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $3.92K.
  • Washington Trust Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
  • Washington Trust Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $9K in Q4 2021.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Washington Trust Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.